Guilt Reduction vs Exposure Therapy for PTSD
(PORT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two therapies for veterans with PTSD who experience significant guilt related to their trauma. It compares Trauma-Informed Guilt Reduction Therapy, which targets guilt and shame, with Prolonged Exposure Therapy (also known as Exposure Therapy), which focuses on reducing PTSD symptoms. The goal is to determine if the new therapy is as effective in reducing PTSD symptoms and depression, and possibly more effective at easing feelings of guilt and shame. Veterans who have served since Operation Enduring Freedom/Operation Iraqi Freedom and experience trauma-related guilt might be a good fit. As an unphased trial, this study offers veterans the chance to explore innovative therapies that could significantly improve their mental health and well-being.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
A previous study found prolonged exposure therapy to be very effective for treating PTSD, with success rates between 65% and 80%. This well-known therapy has been tested with many veterans, showing improvements in PTSD symptoms. These studies reported no major safety issues, suggesting it is generally well-tolerated.
For Trauma-Informed Guilt Reduction Therapy (TrIGR), research shows that nearly half of the participants experienced noticeable reductions in PTSD symptoms after treatment. Reductions in trauma-related guilt were linked to lower PTSD and depression symptoms, indicating positive results. While specific safety data is limited, the therapy involves only a few sessions and focuses on emotional support, which generally suggests it is well-tolerated.
Overall, both therapies have demonstrated effectiveness and are considered safe options for addressing PTSD and related issues.12345Why are researchers excited about this trial?
Researchers are excited about Trauma-Informed Guilt Reduction Therapy because it targets trauma-related guilt, shame, and moral injury, offering a fresh angle compared to traditional PTSD treatments like Prolonged Exposure Therapy. This new therapy is unique because it requires only six sessions, potentially making it a more accessible and quicker option for patients. Additionally, by focusing specifically on emotions that aren't always addressed in standard treatments, it could provide relief for those who haven't fully benefited from existing methods.
What evidence suggests that this trial's treatments could be effective for PTSD?
This trial will compare Prolonged Exposure Therapy and Trauma-Informed Guilt Reduction Therapy (TrIGR) for treating PTSD. Research has shown that Prolonged Exposure Therapy is highly effective for PTSD, with studies reporting significant symptom improvement in 65% to 80% of participants. One study found this therapy more effective than being on a waiting list and as effective as other trauma-focused treatments.
Trauma-Informed Guilt Reduction Therapy (TrIGR), another treatment option in this trial, has shown promise in reducing trauma-related guilt and PTSD symptoms. Research found it led to greater reductions in guilt, depression, and PTSD symptoms compared to other treatments. It addresses distress that other therapies might not cover, potentially offering additional benefits.12678Who Is on the Research Team?
Shannon Kehle-Forbes, PhD
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
This trial is for veterans with PTSD who feel guilt or shame related to their trauma. Participants must be diagnosed with PTSD and have experienced a traumatic event that causes them feelings of guilt.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Trauma-Informed Guilt Reduction Therapy (TrIGR) over 6 weekly sessions or Prolonged Exposure Therapy (PE) over 12 weekly sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Prolonged Exposure Therapy
- Trauma-Informed Guilt Reduction Therapy
Prolonged Exposure Therapy is already approved in United States, European Union for the following indications:
- Posttraumatic Stress Disorder (PTSD)
- Posttraumatic Stress Disorder (PTSD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Veterans Medical Research Foundation
Lead Sponsor
University of Minnesota
Collaborator
Center for Veterans Research and Education
Collaborator